Clinical Trials Browser

Cervical Esophagus Adenocarcinoma

Pancreatic Metastatic Cancer

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Clinical Stage 0 Gastric Cancer AJCC v8

Borderline Resectable Pancreatic Adenocarcinoma

Rectal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Adenocarcinoma Of Esophagus

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Colorectal Neoplasms

Pancreatic Neoplasms, Neoplasms, Basal Cell

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Rectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Gastrointestinal Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Pancreatic Neoplasms

Colorectal Adenocarcinoma

Rectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Rectal Neoplasms

Biliary Tract Neoplasms

Cholangiocarcinoma

Pancreatic Neoplasms

Small Bowel Adenocarcinoma

Biliary Tract Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Colorectal Neoplasms, Cholangiocarcinoma

Locally Advanced Rectal Cancer

Pancreatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

PAMELA70

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

LAP100

LyRICX

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Toco-CoR

PANGEA

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

PROTECT

FRUITFUL

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

TRIBE-C

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

PANCREAS

SOLARIS

FOBEAR

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

CROCOBIL

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Curcumin in Combination With 5FU for Colon Cancer

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

SMART TNT

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

BBOpCo

CAPRI-3 GOIM